Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 653,"Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106.",mammary gland integrity trait,,RS:0003356,WF.WKY-(D5Uwm78-D5Uwm84)/Uwm,female,160 days to 155 days,29,,CMO:0000343,mammary tumor number,,,,8.8,,0.7,3.7696,MMO:0000163,in vivo visual assessment,,0.0,,,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",70305,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)" 653,"Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106.",mammary gland integrity trait,,RS:0003356,WF.WKY-(D5Uwm78-D5Uwm84)/Uwm,female,160 days to 155 days,41,,CMO:0000343,mammary tumor number,,,,8.1,,0.6,3.8419,MMO:0000163,in vivo visual assessment,,0.0,,,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",70307,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)"